Lv1
70 积分 2024-08-30 加入
Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
27天前
已完结
Targeting claudin 18.2 in gastric cancer: a review of emerging biologic agents
2个月前
已完结
[Expert consensus on the diagnosis and clinical management of anaphylaxis]
6个月前
已完结
Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review
8个月前
已完结
[Consensus on clinical diagnosis, treatment and prevention management of chemotherapy induced thrombocytopenia in China(2018)]
8个月前
已完结
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
10个月前
已完结
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
10个月前
已完结
Malignant bowel obstruction
11个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
11个月前
已完结
[Expert consensus on diagnosis and treatment of lung cancer complicated with interstitial lung disease]
1年前
已完结
皖公网安备34019202002308
